April 11, 2026 07:48 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amit Shah promises UCC, ₹3,000 aid per month for women and youth in BJP’s Bengal manifesto | Nitish Kumar takes Rajya Sabha oath; power shift looms in Bihar | Sting video fallout: AIMIM snaps electoral ties with Humayun Kabir in Bengal | Israel says Hezbollah chief’s nephew-cum-secretary killed in Beirut strikes last night | Modi slams TMC on trade, fisheries at Haldia; vows 7th pay commission for govt employees | ‘US military will remain in and around Iran’: Trump amid fragile ceasefire | BJP eyes Assam hattrick, Puducherry comeback; LDF faces Kerala test | Israel claims Hezbollah chief's nephew killed in Beirut strikes last night | Jaishankar’s high-stakes diplomatic tour: EAM to visit UAE this week, first visit amid Middle East conflict | Passport row: Barricades outside Pawan Khera’s Hyderabad house after Himanta Biswa Sarma's warning
Omicron
Pixabay

Russian nasal vaccine effective against Omicron variant: Researchers

| @indiablooms | Mar 20, 2022, at 08:31 pm

Moscow/UNI/Sputnik: The new Russian nasal vaccine against the coronavirus infection has demonstrated effectiveness against the Omicron variant, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.

"Yes, it is being tested against Omicron, it works," Gintsburg said. According to the chief researcher, the new vaccine will be used as a booster, in addition to the Sputnik V shots, for now, until there is enough evidence that this new intranasal vaccine gives the same level of protection as injection.

The Russian health ministry authorized clinical trials of the new intranasal vaccine in October 2021.

In November, Russian President Vladimir Putin offered to become a volunteer in the testing of the new vaccine and said that he felt no side effects after getting the procedure.

Gintsburg told Sputnik earlier this month that the new intranasal vaccine had already been administered to over 100 people, as part of the trials, who showed no negative side effects.

On Friday, the Gamaleya center applied for the registration of the new nasal vaccine against Covid-19. According to Gintsburg, it is expected to be registered earlier than planned.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.